Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CDNST vs Standard Therapy in Crohn's Disease
NCT00271947Phase 2Terminated
- Sponsor
- Northwestern University
- Start
- Apr 2005
- Primary completion
- Apr 2012
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of autologous hematopoietic stem cells in Crohn's disease (2 arms), sponsored by Northwestern University. Primary endpoint: Remission or Clinical Improvement as Assessed by Crohn's Disease Activity Index. Started Apr 2005; status: terminated.
02
Drugs
autologous hematopoietic stem cells
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on NCT00271947.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00271947.